1United Nations Office on Drugs and Crime. World Drug Report. United Nations, 2015.
2European Monitoring Centre for Drugs and Drug Addiction. European Drug Report. Trends and Developments. Publications Office of the European Union, 2015.
3Abdalla, RR, Madruga, CS, Ribeiro, M, Pinsky, I, Caetano, R, Laranjeira, R. Prevalence of cocaine use in Brazil: data from the II Brazilian national alcohol and drug surveys (BNADS). Addict Behav 2014; 39: 297–301.
4Duailibi, LB, Ribeiro, M, Laranjeira, R. Profile of cocaine and crack users in Brazil. Cad Saude Publica 2008; 24: 547–57.
5Dias, AC, Araújo, MR, Dunn, J, Sesso, RC, De Castro, V, Laranjeira, R. Mortality rate among crack/cocaine-dependent patients: a 12-year prospective cohort study conducted in Brazil. J Subst Abuse Treat 2011; 41: 273–8.
6Ribeiro, M, Dunn, J, Laranjeira, R, Sesso, R. High mortality among young crack cocaine users in Brazil: a 5-year follow-up study. Addiction 2004; 99: 1133–5.
7Hoffman, JA, Klein, H, Eber, M, Crosby, H. Frequency and intensity of crack use as predictors of women's involvement in HIV-related sexual risk behaviors. Drug Alcohol Depend 2000; 1: 227–36.
8Merikangas, KR, McClair, VL. Epidemiology of substance use disorders. Hum Genet 2012; 131: 779–89.
9Vakalahi, HF. Adolescent substance use and family-based risk and protective factors: a literature review. J Drug Educ 2001; 31: 29–46.
10Haug, S, Nuñes, CL, Becker, J, Gmel, G, Schaub, MP. Predictors of onset of cannabis and other drugs use in male young adults from a longitudinal study. BMC Public Health 2014; 14: 1202.
11Kendler, KS, Schmitt, E, Aggen, SH, Prescott, CA. Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch Gen Psychiatry 2008; 65: 674–82.
12Bonelli, RM, Koenig, HG. Mental disorders, religion and spirituality 1990 to 2010: a systematic evidence-based review. J Relig Health 2013; 52: 657–73.
13Koenig, HG, King, DE, Carson, VB. Handbook of Religion and Health. Oxford University Press, 2012.
14Miller, L, Wickramaratne, P, Gameroff, MJ, Sage, M, Tenke, CE, Weissman, MM. Religiosity and major depression in adults at high risk: a ten-year prospective study. Am J Psychiatry 2012; 169: 89–94.
15Regnerus, MD, Burdette, A. Religious change and adolescent family dynamics. Soc Q 2006; 47: 175–94.
16Dalgalarrondo, P, Soldera, MA, Filho, HRC, Silva, CAM. Religião e uso de drogas por adolescentes. Rev Bras Psiquiatr 2004; 26: 82–90.
17Bunt, GC, Muehlbach, B, Moed, CO. The therapeutic community: an international perspective. Subst Abuse 2008; 29: 81–7.
18Broekaert, E, Vandevelde, S, Soyez, V, Yates, R, Slater, A. The third generation of therapeutic communities: the early development of the TC for addictions in Europe. Eur Addict Res 2006; 12: 1–11.
19Koenig, HG, Meador, K, Parkerson, G. Religion index for psychiatric research: a 5-item measure for use in health outcomes studies. Am J Psychiatry 1997; 154: 885–6.
20Lucchetti, G, Granero Lucchetti, AL, Peres, MF, Leão, FC, Moreira-Almeida, A, Koenig, HG. Validation of the Duke Religion Index: DUREL (Portuguese Version). J Relig Health 2012; 51: 579–86.
21Bastos, FI, Bertoni, N. Pesquisa Nacional Sobre o Uso de Crack: Quem São os Usuários de Crack e/ou Similares do Brasil? Quantos São Nas Capitais Brasileiras? Editora ICICT/Fiocruz, 2014.
22Sussner, BD, Smelson, DA, Rodrigues, S, Kline, A, Losonczy, M, Ziedonis, D. The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend 2006; 86: 233–7.
23Araújo, RB, Pedroso, RS, Castro, MGT. Adaptação transcultural para o idioma português do Cocaine Craving Questionnaire – Brief. Rev Psiquiatr Clin 2010; 37: 195–8.
24The WHOQOL Group. Development of the World Health Organization WHOQOL-Brief. Quality of life assessment. Psychol Med 1998; 28: 551–8.
25Fleck, MP, Louzada, S, Xavier, M, Chachamovich, E, Vieira, G, Santos, L, et al. Application of the Portuguese version of the instrument for the assessment of Quality of Life of the World Health Organization (WHOQOL-100). Rev Saude Publica 1999; 2: 198–205.
26Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22–33.
27Amorim, P. Mini International Neuropsychiatric Interview (MINI): validation of a short structured diagnostic psychiatric interview. Rev Bras Psiquiatr 2000; 22: 106–15.
28Lai, HM, Cleary, M, Sitharthan, T, Hunt, GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug Alcohol Depend 2015; 1: 1–13.
29Poorolajal, J, Haghtalab, T, Farhadi, M, Darvishi, N. Substance use disorder and risk of suicidal ideation, suicide attempt and suicide death: a meta-analysis. J Public Health (Oxf) 2016; 38: 282–91.
30Regnerus, MD, Elder, GH. Religion and vulnerability among low-risk adolescents. Soc Sci Res 2003; 32: 633–58.
31Falck, RS, Wang, J, Siegal, HA, Carlson, RG. Longitudinal application of the medical outcomes study 36-item short-form health survey with not-in-treatment crack-cocaine users. Med Care 2000; 38: 902–10.
32Van der Meer Sanchez, Z, De Oliveira, LG, Nappo, SA. Religiosity as a protective factor against the use of drugs. Subst Use Misuse 2008; 43: 1476–86.
33Edlund, MJ, Harris, KM, Koenig, HG, Xan, X, Sullivan, G, Mattox, R, et al. Religiosity and decreased risk of substance use disorders: is the effect mediated by social support or mental health status? Soc Psychiatry Psychiatr Epidemiol 2010; 45: 827–36.
34Wichers, M, Gillespie, NA, Kendler, KS. Genetic and environmental predictors of latent trajectories of alcohol use from adolescence to adulthood: a male twin study. Alcohol Clin Exp Res 2013; 37: 498–506.
35Yonker, JE, Schnabelrauch, CA, DeHaan, LG. The relationship between spirituality and religiosity on psychological outcomes in adolescents and emerging adults: a meta-analytic review. J Adolesc 2012; 35: 299–314.